
Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb
10/26/2026
0:00
2:39
Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Bristol Myers Squibb and Tempus AI to advance Alzheimer’s drug development, and health economist Dr. Nadine Zawadzki speaks with The Ron Lanton Report on how value is defined across healthcare.
More episodes from "Pharmaceutical Executive"



Don't miss an episode of “Pharmaceutical Executive” and subscribe to it in the GetPodcast app.








